May 17, 2019 Columns by Ed Tobias MS Is a Pain, and Doctors Should Know It Dear Doctor, Why is it that you, or at least some of your colleagues, think that multiple sclerosis isn’t painful? Did you skip the med school class where they discussed MS?Ā Are you not a neurologist, or are you a neurologist who doesn’t specialize in MS? Whatever the reason, this “MS…
May 13, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: Lemtrada Satisfaction, Limiting Tysabri’s PML Risk, MS and Pregnancy, Infusions vs. Pills #AANAM ā RRMS Patients Switching to Lemtrada Report Greater Satisfaction with Treatment and Improvements in Quality of Life I’m a self-proclaimed secondary progressive, rather than a remitting, multiple sclerosis (MS) person. But a year after round two of Lemtrada (alemtuzumab), I can agree with this report. Several of my…
May 10, 2019 Columns by Ed Tobias Diets and Supplements: Do They Really Help Your MS? When I read online posts from people who treat their multiple sclerosis (MS) with vitamins and supplements, I wonder how many of us do that. And if these supplements really help. The people at the Accelerated Cure Project, which surveys those living with MS about things such as this,…
May 7, 2019 Columns by Ed Tobias MS Meds Lead the Pack as Costs of Neuro Medications Rise Ouch! The out-of-pocket cash that people with multiple sclerosis (MS) lay out for their medications increased 20-fold between 2004 and 2016. That information comes from a study recently published on theĀ NeurologyĀ website.Ā Looked at another way, monthly out-of-pocket costs for MS meds rose from about $15 to about $309 over 12…
May 6, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: Sexual Problems in Women with MS; Aubagio Satisfaction; Cellular Aging and PPMS Women with MS Have Higher Prevalence of Sexual Dysfunction, Study Reveals I’m surprised that someone felt it necessary to conduct a formal study of this. A glance at multiple sclerosis (MS) groups on social media, although unscientific, would suggest that this is a common problem. And if you’re going…
May 3, 2019 Columns by Ed Tobias A Judge Takes a Swing at an Insurance Company’s Denials Robert Scola Jr. is a federal judge in Miami, and he’s just recused himself from a case involving the UnitedHealthcare (UHC) insurance company. The case is one of two filed in Miami over the last two months claiming that UHC has improperly denied coverage for a specific cancer…
April 30, 2019 Columns by Ed Tobias Lemtrada Risks vs. Rewards: Putting the Latest Side Effect Concerns into Perspective There’s been a lot of social media chatter following theĀ recent decision by theĀ European Medicines AgencyĀ (EMA) to initiate a safety review of Lemtrada (alemtuzumab). The EMA has restricted use of the medication within the European Union (EU) while the review is underway. That’s worrying some people who are…
April 29, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: Tai Chi Study, Lemtrada Safety Review, Personalized Treatment, Online Depression Therapy Study Will Explore Benefits of Tai Chi, Meditation on MS Patientsā Balance I’ve tried yoga to help with my balance and flexibility and found it useful. But tai chi scares me a little ā it seems too difficult. Maybe, if the results of this study are very positive, I’ll…
April 26, 2019 Columns by Ed Tobias Is It OK for Your Doctor to Hug You? Former Vice President Joe Biden has been in some hot water recently because of his habit of hugging some of the people he meets. More generally, in today’s society, some of the casual social touching that once went on, particularly in the workplace, has become out of bounds.
April 23, 2019 Columns by Ed Tobias Are Medical Mouse Studies Worth Reporting? People who cover medical issues often write about mouse studies. These stories can regularly be found on traditional news outlets, both broadcast and print, as well as online platforms. That includes the website on which you’re reading this column. I’m one of the mouse study writers, though I try to…
April 16, 2019 Columns by Ed Tobias Cancer Medication Shows Promise in Treating Dangerous Brain Infection PML, Small-scale Study Finds Progressive multifocal leukoencephalopathy, more commonly referred to as PML, is a brain infection that’s frequently fatal.Ā PML is particularly dangerous to people with MS, which is why I’m interested in a report about a medication that’s showing promise as a PML treatment. The concern for people with MS is…
April 15, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: MS Misdiagnoses, Mineral Intake Risk Study, Hormonal Changes, Rituximab and Vitamin D MS Misdiagnosis Too Common, Puts Patients in Unnecessary Peril from Therapies, Study Reveals Many people who have multiple sclerosis (MS) report that it’s taken doctors years to come up with their diagnoses. So, it’s interesting to read a story about the opposite: those whose MS diagnoses were…
April 12, 2019 Columns by Ed Tobias Immunocompromised? Watch Out for the C. Auris Fungus. Most healthy people probably don’t have to worry about a fungus called Candida auris, or simply C. auris. But if your immune system is compromised, it’s a different story. Health officials say C. auris should be of special concern to people whose immune systems are not at full strength,…
April 9, 2019 Columns by Ed Tobias 3 Strategies for Dealing with the High Costs of Medications It’s tough paying for medications. Whether they’re for multiple sclerosis (MS) or another illness, Americans are having a hard time coming up with the cash needed to cover the cost of their meds. Many people are developing workarounds and compromises to deal with the problem. And in some…
April 8, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: Mayzent Approval Surprises, Myelin Repair, Monitoring Nerve Inflammation Cleveland Clinic Neurologist Applauds Mayzentās FDA Approval, But Surprised by Those It May Not Treat When I wrote my “MS Wire” column a few days after Mayzent’s approval, I wondered why the FDA had OK’d the medication for active secondary progressive multiple sclerosis (SPMS), but not…
April 2, 2019 Columns by Ed Tobias Mayzent Joins the MS Medication Arsenal, But I Have Questions As you might have heard, a disease-modifying therapy (DMT) for patients with active secondary progressive multiple sclerosis (SPMS) was approved a few days ago. That’s great news. A medication targeting SPMS is overdue, but it could be better. The DMT is Mayzent (siponimod), a tablet that’s taken…
April 1, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: Reaction to SPMS DMT Approval, Ozanimod’s FDA Application, Caregiving Partnerships, a New Preventive Medication? MS Patient Groups React Favorably to Mayzent Approval, But Question Therapyās Price Tag The approval of this medication is very good news. However, as the headline indicates, it comes with a relatively hefty cost. It’s approved for active secondary progressive multiple sclerosis (SPMS), and many of us have SPMS…
March 29, 2019 Columns by Ed Tobias Some Thoughts About Controlling Your MS Bladder There are two types of people with MS: Those who have bladder problems and those who will have them. That may be an oversimplification but Iād be willing to bet that you, like me, have had that gotta-gotta-go problem too many times to count. Sometimes you make it…
March 25, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: Walking Med Trial Recruiting, DMT Risk Tolerance, Sex and MS Phase 3 Trial of ADS-5102 Recruiting Participants of All MS Types This medication is similar to Ampyra (dalfampridine) because its goal is to improve walking in those with MS. It sure would be nice if we had another medication approved that could do that. Though this trial began recruiting…
March 22, 2019 Columns by Ed Tobias Things to Know If You’re Thinking About Leaving Your Neurologist If you’re a member of the babyĀ boomer generation, or if you just like the music of the 1960s and ’70s, you probably know Paul Simon’s “50 Ways to Leave Your Lover“: “‘The problem is all inside your head,’ she said to me. ‘The answer is easy…
March 19, 2019 Columns by Ed Tobias DMT Choice for Your MS Is Your Decision About 15 disease-modifying therapies (DMTs) are available to treat MS these days. So, choosing which to use can be daunting. I’ve been treated with four DMTs since I was first prescribed Avonex (interferon beta-1a) back in 1996. Each time I’ve switched treatments, my neurologist has suggested a number of…
March 18, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: Non-contrast MRIs, Stem Cell Study Seeks Subjects, Postpartum Relapses, Which DMT? Non-contrast MRI Effective in Monitoring Progression of MS, Study Shows There’s been increased interest in the risks versus the benefits of using gadolinium to make lesions more visible on an MRI. The U.S. Food and Drug Administration issued an advisory last year raising the level of…
March 15, 2019 Columns by Ed Tobias Pediatric MS Can Be āDiagnostic Odyssey’ A post in one of the MS social media groups I follow recently asked whether kids can have MS. The writer was worried about her 3-year-old. One commenter replied that her son was diagnosed when he was 9. But, she wrote, his symptoms actually began to appear when he…
March 12, 2019 Columns by Ed Tobias Are MS Patients Using Too Many Medications? Have you ever heard of the word “polypharmacy”? I saw the word for the first time today. It’s generally defined as taking many medications together. There’s been debate over how many is “many,” but a number generally used is five or more. That describes me. I take…
March 11, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: A Cure for MS?, MS App, Robot for Balance, Botox for Spasticity All of the stories in this week’s column come from the recently held Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) forum, heldĀ Feb. 28 to March 2 inĀ Dallas, Texas. #ACTRIMS2019 ā Forum Leaders Discuss: āWill There Be a Cure for MS?ā A reporter for…
March 8, 2019 Columns by Ed Tobias Things Your Doctor Didn’t Tell You About Living with MS A recent article in The New York Times hit the nail on the head when it comes to describing the world we live in with MS. But the article isn’t about MS. The Times‘Ā Tessa Miller writes about Crohn’s disease, a type of inflammatory bowel disorder. Like MS, Crohn’s…
March 5, 2019 Columns by Ed Tobias Two Different Approaches to Providing Online MS Help I received an email recently from the National Multiple Sclerosis Society in the U.S. promoting a searchable database of “credible doctors and resources.” A few days later, I happened to run across another online multiple sclerosis (MS) information service hosted by the HealthCare Journey website. They call it…
March 4, 2019 Columns by Ed Tobias MS News that Caught My Eye Last Week: New DMT, Stem Cell Trial, Pediatric MS Treatment Study FDA Will Review New Drug Application of Diroximel Fumarate for Relapsing Forms of MS The good news: Another disease-modifying therapy (DMT) has taken a step toward approval in the U.S. The discouraging news: It’s another DMT designed to treat relapsing forms of multiple sclerosis. More than a…
March 1, 2019 Columns by Ed Tobias Bravo to Selma Blair and Her Cane for Appearing at the Oscars Over the past few months, I’ve had a few things to say about actress Selma Blair and the very public way in which she’s been handling her MS diagnosis. When Blair went public with her MS last October, she did it on Instagram, writing,Ā “I am…
February 26, 2019 Columns by Ed Tobias A Warning About ‘Young Plasma’ Treatments for Multiple Sclerosis Plasma is the fluid part of our blood that carries nutrients and blood cells through our bodies. Donated plasma can save the lives of burn and injury victims and it’s used as a treatment for hemophilia and other autoimmune diseases. Recently, some treatment centers in the United States…